Abstract
Panton–Valentine leukocidin (PVL), a pore-forming cytotoxic secreted toxin, has been associated with severe Staphylococcus aureus pneumonia and prototypical skin lesions. The reported incidence and prevalence of PVL-positive S. aureus (PVLP-SA) varies globally and suffers from a selective reporting bias towards community-associated methicillin-resistant S. aureus (CA-MRSA). Recent studies, however, have identified PVL-positive methicillin-susceptible S. aureus (MSSA) more frequently than previously expected. In this review, a group of experts from four continents affiliated with the International Society of Chemotherapy (ISC) offer a position statement on the important aspects of PVL in S. aureus epidemiology, antimicrobial treatment and decolonisation, and aim to highlight future areas for collaboration and research.
Original language | English |
---|---|
Pages (from-to) | 16-25 |
Number of pages | 10 |
Journal | International Journal of Antimicrobial Agents |
Volume | 51 |
Issue number | 1 |
Early online date | 22 Nov 2017 |
DOIs | |
Publication status | Published - Jan 2018 |
Bibliographical note
Funding: None.Competing interests: None declared.
Ethical approval: Not required.
Keywords
- PVL
- CA-MRSA
- MSSA
- S. aureus
- infection control